2012-003515-58: Comparative effectiveness of 1 month of ticagrelor plus aspirin followed by ticagrelor on its own versus a current-day intensive antiplatelet therapy with 2 antiplatelet drugs in patients who are having a stent inserted into their coronary artery. |
|
|
| Ongoing | 3/4 | 2000 | Europe | Brilique, Aspirin, Clopidogrel, Acetylsalicylic Acid, Brilique, Brilique | ECRI, , European Cardiovascular Research Institute, Biosensors Europe SA, Astra Zeneca, The Medicines Company, | Subjects either male or female eligible for percutaneous coronary intervention (PCI) with lesions suitable for stent implantation who meet all eligibility criteria and provide written informed consent will be included. Of note, inclusion criteria will be kept comprehensive to reflect routine clinical practice (i.e. “real world, all-comers” patients). | | | | |